Barclays maintains Xencor at Overweight, raises target to $35
Barclays maintained an Overweight rating on Xencor and raised its price target to $35.00 from $27.00.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.